Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, indicating a newer version of the page content. This reflects a metadata update rather than substantive changes to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now indicates recruitment is closed and adds new guidance sections to help readers navigate and join the study. It also updates the Intervention/Treatment label and the page revision to v3.6.0.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling an updated version of the page's content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a newer page version. This change appears to be a minor documentation update and does not modify study details or content.SummaryDifference0.0%

- Check69 days agoChange DetectedThis reflects a formatting/labeling change for the Chile location name (Valparaíso/Región de Valparaíso shown as Valparaiso) and a minor site revision update (v3.5.0 to v3.5.3). No other study details appear to be modified.SummaryDifference0.0%

- Check104 days agoChange DetectedAdded Naples, Italy, 80131 to the study locations and removed Napoli, Italy, 80131.SummaryDifference0.0%

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.